SE8202357L - Antihypertensiva farmaceutiska beredningar - Google Patents
Antihypertensiva farmaceutiska beredningarInfo
- Publication number
- SE8202357L SE8202357L SE8202357A SE8202357A SE8202357L SE 8202357 L SE8202357 L SE 8202357L SE 8202357 A SE8202357 A SE 8202357A SE 8202357 A SE8202357 A SE 8202357A SE 8202357 L SE8202357 L SE 8202357L
- Authority
- SE
- Sweden
- Prior art keywords
- compsns
- iii
- salidiuretic
- endralazine
- pindolol
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- ALAXZYHFVBSJKZ-UHFFFAOYSA-N endralazine Chemical compound C1CC=2N=NC(NN)=CC=2CN1C(=O)C1=CC=CC=C1 ALAXZYHFVBSJKZ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002029 endralazine Drugs 0.000 title abstract 2
- 229960002508 pindolol Drugs 0.000 title abstract 2
- 230000000054 salidiuretic effect Effects 0.000 title abstract 2
- LBXHRAWDUMTPSE-AOOOYVTPSA-N 4-chloro-N-[(2S,6R)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide Chemical compound C[C@H]1CCC[C@@H](C)N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 LBXHRAWDUMTPSE-AOOOYVTPSA-N 0.000 title 1
- 230000003276 anti-hypertensive effect Effects 0.000 title 1
- 229960004070 clopamide Drugs 0.000 title 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 title 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- JZQKKSLKJUAGIC-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1C=CN2 JZQKKSLKJUAGIC-UHFFFAOYSA-N 0.000 abstract 2
- 229920002261 Corn starch Polymers 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000001175 calcium sulphate Substances 0.000 abstract 1
- 235000011132 calcium sulphate Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008119 colloidal silica Substances 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- AQCHWTWZEMGIFD-UHFFFAOYSA-N metolazone Chemical compound CC1NC2=CC(Cl)=C(S(N)(=O)=O)C=C2C(=O)N1C1=CC=CC=C1C AQCHWTWZEMGIFD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002817 metolazone Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 235000012222 talc Nutrition 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH178579A CH643457A5 (de) | 1979-02-22 | 1979-02-22 | Pharmazeutische praeparate zur behandlung der hypertonie. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8202357L true SE8202357L (sv) | 1982-04-15 |
Family
ID=4218544
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8001121A SE8001121L (sv) | 1979-02-22 | 1980-02-13 | Antihypertensiva farmaceutiska beredningar |
| SE8202357A SE8202357L (sv) | 1979-02-22 | 1982-04-15 | Antihypertensiva farmaceutiska beredningar |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8001121A SE8001121L (sv) | 1979-02-22 | 1980-02-13 | Antihypertensiva farmaceutiska beredningar |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS55115823A (sv) |
| AT (1) | AT378915B (sv) |
| AU (1) | AU538599B2 (sv) |
| BE (1) | BE881763A (sv) |
| CA (1) | CA1147657A (sv) |
| CH (1) | CH643457A5 (sv) |
| DE (1) | DE3005029A1 (sv) |
| FR (1) | FR2449450A1 (sv) |
| GB (1) | GB2044101B (sv) |
| HU (1) | HU187271B (sv) |
| IE (1) | IE49073B1 (sv) |
| IL (1) | IL59432A (sv) |
| IT (1) | IT1145433B (sv) |
| MY (1) | MY8500619A (sv) |
| NL (1) | NL8001000A (sv) |
| NZ (1) | NZ192924A (sv) |
| PH (1) | PH17118A (sv) |
| PT (1) | PT70855A (sv) |
| SE (2) | SE8001121L (sv) |
| ZA (1) | ZA801018B (sv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2537434A1 (fr) * | 1982-12-09 | 1984-06-15 | Sandoz Sa | Composition pharmaceutique d'endralazine sous forme retard |
| GB2367242B (en) * | 2000-09-21 | 2004-07-28 | Henderson Morley Res & Dev Ltd | Antiviral treatment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2458155A1 (de) * | 1973-12-19 | 1975-07-03 | Sandoz Ag | Neue pharmazeutische praeparate |
-
1979
- 1979-02-22 CH CH178579A patent/CH643457A5/de not_active IP Right Cessation
-
1980
- 1980-02-11 DE DE19803005029 patent/DE3005029A1/de active Granted
- 1980-02-13 SE SE8001121A patent/SE8001121L/sv not_active Application Discontinuation
- 1980-02-15 GB GB8005245A patent/GB2044101B/en not_active Expired
- 1980-02-18 BE BE1/9727A patent/BE881763A/fr not_active IP Right Cessation
- 1980-02-19 NL NL8001000A patent/NL8001000A/nl not_active Application Discontinuation
- 1980-02-20 NZ NZ192924A patent/NZ192924A/en unknown
- 1980-02-20 CA CA000346083A patent/CA1147657A/en not_active Expired
- 1980-02-20 IT IT47950/80A patent/IT1145433B/it active
- 1980-02-20 IL IL59432A patent/IL59432A/xx unknown
- 1980-02-20 PT PT70855A patent/PT70855A/pt unknown
- 1980-02-20 IE IE336/80A patent/IE49073B1/en unknown
- 1980-02-20 AU AU55742/80A patent/AU538599B2/en not_active Ceased
- 1980-02-20 FR FR8003669A patent/FR2449450A1/fr active Granted
- 1980-02-21 PH PH23672A patent/PH17118A/en unknown
- 1980-02-21 AT AT0095580A patent/AT378915B/de not_active IP Right Cessation
- 1980-02-21 HU HU80402A patent/HU187271B/hu unknown
- 1980-02-21 JP JP1980480A patent/JPS55115823A/ja active Pending
- 1980-02-22 ZA ZA00801018A patent/ZA801018B/xx unknown
-
1982
- 1982-04-15 SE SE8202357A patent/SE8202357L/sv not_active Application Discontinuation
-
1985
- 1985-12-30 MY MY619/85A patent/MY8500619A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY8500619A (en) | 1985-12-31 |
| BE881763A (fr) | 1980-08-18 |
| CA1147657A (en) | 1983-06-07 |
| IE49073B1 (en) | 1985-07-24 |
| PT70855A (fr) | 1980-03-01 |
| IT8047950A0 (it) | 1980-02-20 |
| FR2449450B1 (sv) | 1983-07-22 |
| ZA801018B (en) | 1981-09-30 |
| NZ192924A (en) | 1984-05-31 |
| IL59432A (en) | 1984-08-31 |
| DE3005029A1 (de) | 1980-09-04 |
| PH17118A (en) | 1984-06-01 |
| ATA95580A (de) | 1985-03-15 |
| IE800336L (en) | 1980-08-22 |
| AT378915B (de) | 1985-10-25 |
| JPS55115823A (en) | 1980-09-06 |
| GB2044101B (en) | 1983-09-07 |
| NL8001000A (nl) | 1980-08-26 |
| SE8001121L (sv) | 1980-08-23 |
| AU538599B2 (en) | 1984-08-23 |
| IL59432A0 (en) | 1980-05-30 |
| AU5574280A (en) | 1980-08-28 |
| FR2449450A1 (fr) | 1980-09-19 |
| CH643457A5 (de) | 1984-06-15 |
| IT1145433B (it) | 1986-11-05 |
| GB2044101A (en) | 1980-10-15 |
| HU187271B (en) | 1985-12-28 |
| DE3005029C2 (sv) | 1987-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2201264A1 (en) | Immediate release ph-independent solid dosage form of cisapride | |
| JP2523726B2 (ja) | 固体組成物およびその製造方法 | |
| NO176203C (no) | Fremgangsmåte for fremstilling av ibuprofentabletter med forsinket frigjöring | |
| CA2232450A1 (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
| DE69110969D1 (de) | Verwendung von Triclosan zur Behandlung von Krankheiten des Gastrointestinaltraktes. | |
| NZ218235A (en) | Effervescent ibuprofen composition | |
| NO20065390L (no) | Farmasoytisk preparat i fast enhetsdoseringsform | |
| CY2460B1 (en) | Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors. | |
| DE69230475T2 (de) | Verzögerte Freigabe Matrix für Arzneimittel | |
| KR890701102A (ko) | 제약학적 조성물 | |
| HUP0105463A2 (hu) | Divalproex-nátriumot tartalmazó szabályozott felszabadulású készítmény | |
| NO865195L (no) | Fremgangsmte for fremstilling av et retardpreparat av ibuprofen. | |
| EA200001201A2 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
| NO307686B1 (no) | Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter | |
| SE8202357L (sv) | Antihypertensiva farmaceutiska beredningar | |
| CA2105541A1 (en) | Programmed Release Tablets Containing Naproxen | |
| US3039922A (en) | Method of administering tablets having decongestant and anti-histaminic activity | |
| DK162017B (da) | Farmaceutisk tablet med kontrolleret frigivelse og fremgangsmaade til dens fremstilling | |
| EP0335017A3 (en) | Novel use of trazodone | |
| DK166259C (da) | Oral tablet til ph-uafhaengig frigivelse | |
| ES2061394A1 (es) | Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada. | |
| KR800001387B1 (en) | Process for preparing sustained release formulation | |
| GB1565686A (en) | Anti-hypertensive compositions | |
| TH28052C3 (th) | สารเตรียมทางยาของม็อคซิฟลอซาซิน | |
| KR950031064A (ko) | 젬피브로질 함유 약제학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8202357-3 Effective date: 19851011 Format of ref document f/p: F |